Related Experiment Video

Updated: Aug 18, 2026

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

The MPTP model of Parkinson's disease

Richard Jay Smeyne1, Vernice Jackson-Lewis

  • 1Department of Developmental Neurobiology, Saint Jude Children's Research Hospital, Memphis, TN 39105, USA. richard.smeyne@stjude.org

Brain Research. Molecular Brain Research
|March 26, 2005
PubMed

Insights

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes biochemical and cellular changes mimicking Parkinson's disease. This review details MPTP's molecular actions and its role in killing substantia nigra neurons.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons.
  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin that induces parkinsonian symptoms in humans and animals.
  • MPTP serves as a crucial tool for modeling PD in research settings.

Purpose of the Study:

  • To review the molecular mechanisms underlying MPTP-induced neurotoxicity.
  • To elucidate the biotransformation pathways of MPTP.
  • To describe the cellular interactions leading to substantia nigra pars compacta (SNpc) neuron death.

Main Methods:

  • Literature review of studies on MPTP neurotoxicity.
  • Analysis of biochemical and cellular data related to MPTP.
  • Examination of the interplay between neurons and glia in MPTP-induced damage.

Main Results:

  • MPTP undergoes peripheral metabolism to its active toxic form, MPP+.
  • MPP+ is selectively taken up by dopaminergic neurons.
  • MPTP induces oxidative stress, mitochondrial dysfunction, and neuroinflammation, leading to SNpc neuron death.

Conclusions:

  • MPTP neurotoxicity provides a valuable model for understanding PD pathogenesis.
  • Understanding MPTP's molecular actions can inform therapeutic strategies for PD.
  • The interplay between neurons and glia is critical in MPTP-induced neurodegeneration.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease04:08

Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease

Published on: January 18, 2021

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.